We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
planarTECH is an engineering company founded in 2014 as a provider of process equipment for the growth and characterisation of graphene and other emerging 2D materials. Its core product line is the planarGROW Chemical Vapor (CVD) system. The company has the ability to deliver scalable production systems that allow lower-cost production of graphene in comparison to other options currently available in the market. Moreover, from 2014 to 2019, the company’s cumulative revenues exceeded £5 million. The company's products have been installed and used by faculties and students at prestigious universities like Stanford University (USA), IIT- Bombay (India), Deakin University (Australia), and many others. From the investment, the company will utilise 45% as working capital, 30% in Capital Expenditures (CAPEX), 15% in R&D and 10% in hiring additional staff.

Pitch Rated

47%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £425,061
Ember Snacks (ES) is a sustainable meat snack brand that aims to end factory farming in the meat industry. It works directly with farmers committed to using high welfare and regenerative practices to improve soil health and encourage wildlife on their farms. Since its launch in 2017, ES's products have been stocked in over 2,000 distribution points across the UK, including Sainsbury’s and Waitrose. It also argues that it is the most reviewed meat snack brand on Amazon across the UK and Europe, with nearly 4,000 reviews. The company asserts that its products are stocked in 200 Stonegate pubs, supported by field activation. It earned over £1.75 million in sales in 2020, won a medal at the Charcuterie Live Awards 2021, and received over 35 pieces of press coverage in 2021. ES states it will use the investment to discourage factory farming, build its team, grow distribution channels in major UK supermarkets, launch a campaign to highlight factory farming practices, reach out to new customers, and launch new products.

Pitch Rated

46%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,420,578
BabyChum is a bespoke marketplace for independent family, baby & parent-related gifts. It aims to be a significant contender in the estimated £10 billion UK baby market. The company has onboarded 300 vendors and witnessed over 70,000 unique visitors in 6 months since launching in April 2020. It has also secured several partnerships with notable entities like Vodafone and Craft Gin Club. BabyChum has received press coverage in publications like OK! and Mother & Baby magazine. It has a combined social following of over 10,000 across Instagram & TikTok. The company will use the investment towards digital marketing to boost sales and update its marketplace software to enhance both supply and consumer experiences.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £68,545
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
The Stem is an online garden centre aiming to become a leading digital brand in the £7.5 billion per annum UK garden retail market. It is on a mission to make plants and gardening more accessible than ever and in the most sustainable way possible. The company has made over 7,880 deliveries to 6,800 customers across London since launching its new website in March 2020. The Stem has a 97% Net Promoter Score (NPS) and 4.97/5* customer rating. The company will use the investment to expand its product categories and catchment area, build its team and brand, develop its content platform and supply chain.

Pitch Rated

40%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £550,008
Nikalyte is a specialist in nanoparticles research and development (R&D) as well as commercialisation in various application areas such as cell binding, cell separation, drug delivery, catalysis, nano-photonics, and electrochemistry. The company is developing a nanoparticle generator, which will enable researchers to produce nanoparticles of almost any metal or alloy on almost any substrate via a user-friendly interface. Nikalyte is offering free nanoparticle samples to researchers investigating antiviral materials, such as Copper and Silver, towards developing a vaccine for Covid-19. The company also offers a consultancy service that provides advice on nanoparticle applications and ultra-high vacuum systems. The company aims to use the investment to scale its business.

Pitch Rated

37%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Andersen fills the gap by producing intelligent, strong and customizable charging points that can be happily used by customers at home. It has proved itself as a premium provider in the rapidly growing electric vehicle home charger market. The company has witnessed an increase in growth by 10x in 2018 and a third of all sales in the last three months. Andersen has been featured in The Times, BBC London and much more famous press. The company has received 5* on Google review and 'Great' on Trustpilot. It will be using funds to scale up the production and accelerate the growth.

Pitch Rated

0%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £588,560
Callaly is the UK’s first female care B-Corp that delivers subscription-based organic cotton period products. The company has invented and patented the 'Tampliner', a combination of an organic cotton tampon with a soft mini-liner for built-in leak protection, with a clean insertion and removal, and no hard plastic applicator. It is multi-patented in 30 countries. The company has developed bespoke robotic machinery to automate production at a UK facility. In a £26 billion global femcare market, Callaly claims that its potential tampliner market would constitute 2% to 4% by 2024. The company has received rave reviews from magazines such as Cosmopolitan and Grazia. Callaly plans to begin sales in Europe in the third quarter of 2020 followed by sales in the US and Asia in 2021.
days to go: Expired investment: £1,704,460
Perkier is the UK’s fastest growing healthy snack bar brand. It asserts that its bars are 100% plant based, contain 60% less sugar, and are free from gluten and palm oil. Perkier aspires to dominate the global snack bar market that is worth $22 billion. The company claims that its products are distributed in every Sainsbury’s supermarket, in over 450 Morrisons stores and over 400 ASDA stores. It further points out that it is listed in major foodservice companies including Compass, Brakes and Bidfood. The company has over 55,000 followers across social media, and a brand ambassador program including team GB Olympians reaching 1.6 million people. Perkier states it will use the investment to expand its team, increase digital marketing, and invest in innovation.  
days to go: Expired investment: £811,695
Cell Guidance Systems is developing a technology called PODS (Polyhedrin Delivery System) PODS allow them to deliver therapeutic proteins accurately and over long periods of time. PODS enable proteins to treat diseases, such as Parkinson’s disease and osteoarthritis.
days to go: Expired investment: £836,370
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph